Lennox-Gastaut syndrome treatment adjunct

Lennox-Gastaut syndrome is a severe developmental and epileptic encephalopathy primarily presenting in early childhood and persisting throughout life The central nervous system condition is clinically characterized by a classic triad of drug-resistant, polymorphic seizures—predominantly tonic, atonic drop, and atypical absence seizures—alongside progressive cognitive impairment and distinct electroencephalographic features, notably interictal slow spike-and-wave discharges and paroxysmal fast ac...

Lennox-Gastaut syndrome is a severe developmental and epileptic encephalopathy primarily presenting in early childhood and persisting throughout life Because the underlying seizure burden is profoundly refractory to single-agent regimens, adjunctive treatment involves using add-on therapies in combination with baseline antiseizure medications to optimize seizure reduction and mitigate associated morbidity

The central nervous system condition is clinically characterized by a classic triad of drug-resistant, polymorphic seizures—predominantly tonic, atonic drop, and atypical absence seizures—alongside progressive cognitive impairment and distinct electroencephalographic features, notably interictal slow spike-and-wave discharges and paroxysmal fast activity during sleep

The central nervous system condition is clinically characterized by a classic triad of drug-resistant, polymorphic seizures—predominantly tonic, atonic drop, and atypical absence seizures—alongside progressive cognitive impairment and distinct electroencephalographic features, notably interictal slow spike-and-wave discharges and paroxysmal fast activity during sleep

Because the underlying seizure burden is profoundly refractory to single-agent regimens, adjunctive treatment involves using add-on therapies in combination with baseline antiseizure medications to optimize seizure reduction and mitigate associated morbidity